Table 2.
Estimated the proportion of overdiagnosis based on overdiagnosis-embedded disease natural history model in three studies.
| Study | Control group population | Mean of Follow-up time | Predicted CRC from the digital screened twin, E(t) | Observed CRC from the control group, U(t) | Overdiagnosis (%) (95% CI) |
|---|---|---|---|---|---|
| Invasive cancer only | |||||
| Taiwan population-based studya | 5,417,699 | 11.0 | 66,339 | 63,616 | 4.16 (2.61,5.78)c |
| Including HGD | |||||
| Taiwan population-based studya | 5,417,699 | 11.0 | 79,469 | 72,587 | 9.90 (8.41,11.42)c |
| UK trial | 74,998 | 8.5 | 931 | 856 | 8.79 (8.28,9.65) |
| Demark trial | 30,966 | 10.0 | 528 | 483 | 9.33 (8.81,10.20) |
| With consideration of adenoma removal | |||||
| Taiwan population-based studyb | 5,417,699 | 11.0 | 84,425 | 72,587 | 15.83 (15.23, 16.46)c |
aWithout consideration of adenoma.
bWith consideration of adenoma.
cWith consideration of competing risk of death.